Amp Energy India announced this week it has commissioned a 5 MW solar power plant for Bharat Serum and Vaccines Ltd (BSV), one of India’s leading vaccine biopharmaceutical majors. The solar project is located in the Osmanabad district of Maharashtra and supplies solar power to BSV’s manufacturing facility in Ambernath, Maharashtra, under open access.
The PV plant will meet about 65% of BSV’s annual energy needs and will help it achieve 35% savings on its overall energy costs on a year-on-year basis. The plant will also help BSV offset about 6,560 metric tons of CO2 per annum, stated the developer.
Amp Energy India is headquartered in New Delhi with regional offices in Mumbai, Bangalore, and Kolkata. It has a total renewables portfolio of 2 GW+ spread across 15 states in India, which includes a balanced mix of C&I and utility-scale projects.
Amp Energy India provides renewable energy solutions across technologies such as solar, wind, hybrids, storage, and energy management.
This content is protected by copyright and may not be reused. If you want to cooperate with us and would like to reuse some of our content, please contact: firstname.lastname@example.org.
By submitting this form you agree to pv magazine using your data for the purposes of publishing your comment.
Your personal data will only be disclosed or otherwise transmitted to third parties for the purposes of spam filtering or if this is necessary for technical maintenance of the website. Any other transfer to third parties will not take place unless this is justified on the basis of applicable data protection regulations or if pv magazine is legally obliged to do so.
You may revoke this consent at any time with effect for the future, in which case your personal data will be deleted immediately. Otherwise, your data will be deleted if pv magazine has processed your request or the purpose of data storage is fulfilled.
Further information on data privacy can be found in our Data Protection Policy.